News room
TechnoPhage: TA101 GOCLIN European funded project for the development of an innovative product for the treatment of rheumatoid arthritis
A leading consortium of industrial partners has been awarded a grant by the Seventh Framework Program of the European Union for an innovative...
New patent granted to TechnoPhage/Lusomedicamenta
New patent granted to TechnoPhage/Lusomedicamenta Title: Antibacterial Phage, Phage Peptides and Methods of Use Thereof Office: United States Patent...
New patent granted to TechnoPhage
New patent granted to TechnoPhage: Title: Engineered Rabbit Antibody Variable Domains and Uses Thereof Office: The Registry of Patents Singapore...
TechnoPhage invited to be present at National Association of Rheumatoid Arthritis Patients Symposium
TechnoPhage invited to present Rheumatoid Arthritis therapeutics development programme at National Association of Rheumatoid Arthritis Patients...
TechnoPhage invited to present at the National Symposium of Portuguese Association of the Pharmaceutical Industry – APIFARMA
TechnoPhage invited to present at the National Symposium of Portuguese Association of the Pharmaceutical Industry - APIFARMA: "O Valor da Inovação:...